Rare drug sponsors baulk at PBAC

By Megan Brodie 1 year ago | In Companies, Products, Reimbursement
  • 1 year ago
Specialised Therapeutics CEO Carlo Montagner

19 September 2022 While the TGA has provisionally approved two therapies from a new class…

This is subscriber-only content. Please login to continue reading.